Tag Archives: Technical Director

Business, Finance, Occupation & Industry

MOL Group and Wood Group Executives Join AspenTech OPTIMIZE™ 2013 Keynote Lineup

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

MOL Group and Wood Group Executives Join AspenTech OPTIMIZE™ 2013 Keynote Lineup

Dr. Béla Kelemen, SVP, MOL Group Supply Chain Management, and John Kearney, Technical Director, Wood Group to Share Industry Perspectives for Global Process Manufacturing and Engineering Companies

BURLINGTON, Mass.–(BUSINESS WIRE)– Aspen Technology, Inc. (NAS: AZPN) , a leading provider of software and services to the process industries, announced the addition of Dr. Béla Kelemen, Senior Vice President of MOL Group Supply Chain Management (SCM), and John Kearney, Technical Director of Wood Group, to address AspenTech’s global audience at OPTIMIZE 2013. Kelemen and Kearney join Professor George Stephanopoulos of the Massachusetts Institute of Technology (MIT), and AspenTech’s President and CEO Mark Fusco and Executive Vice President, Manolis Kotzabasakis, as headline speakers at OPTIMIZE 2013‘s opening plenary session.

Dr. Kelemen is Senior Vice President of MOL Group Supply Chain Management. Previously, he served as Senior Vice President of MOL Group Refining and Marketing and Vice President of MOL Group Refining. Before joining MOL Group, Kelemen held various senior-level sales and trading roles, including Director of Refinery & Marketing at Slovnaft, where he now serves as a board member.

John Kearney, Technical Director, Wood Group, has more than 30 years of industry experience, holding senior leadership positions in engineering, construction, and operations and maintenance. He has worked with the world’s leading Exploration & Production companies including Shell, BP and ExxonMobil.

Professor George Stephanopoulos is the Arthur D. Little Professor of Chemical Engineering at MIT, and a Principal Investigator in the Process Systems Engineering Lab. He has received numerous honors and awards over the years, and is the author of Intelligent Systems in Process Engineering: Paradigms for Product and Process Design and Chemical Process Control: An Introduction to Theory and Practice.

About the AspenTech OPTIMIZE Conference

AspenTech’s OPTIMIZE is the only conference dedicated to the exchange of engineering, manufacturing, and supply chain best practices for the process industries. OPTIMIZE brings together thought leaders, influencers, and experts from the top process manufacturers and engineering firms worldwide to share insight to reduce costs, improve margins, and increase profit using aspenONE® software.

Featuring nearly 100 real-world cases presented by AspenTech customers, OPTIMIZE 2013 will take place in Boston from May 6-8. Sponsors and media partners include Microsoft, AIChE, Applied Control

From: http://www.dailyfinance.com/2013/04/11/mol-group-and-wood-group-executives-join-aspentech/

Business, Finance, Occupation & Industry

Illumina Launches TruSight™ Tumor Content Set

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Illumina Launches TruSight™ Tumor Content Set

Enables Somatic Variant Detection in Solid Tumors Using Next-Generation Sequencing (NGS)

SAN DIEGO–(BUSINESS WIRE)– Illumina, Inc. (NAS: ILMN) today announced the next product in its TruSight line of content sets, TruSight Tumor, for NGS-based somatic variant detection in solid tumors. TruSight Tumor provides optimized amplicon-based library preparation of 26 oncogenes and tumor suppressor genes selected for their involvement in common solid tumors, including lung, colon, melanoma, gastric, and ovarian cancer.

TruSight Tumor also offers a comprehensive NGS-based tumor profiling solution that provides a broader and more cost-effective view of tumor heterogeneity compared to genotyping-based methods. Researchers can simultaneously detect somatic changes in multiple genes across the tumor genome, as referenced in industry guidelines, as well as emerging biomarkers implicated in pharmaceutical clinical trials. Designed for use with formalin-fixed paraffin-embedded (FFPE) samples, TruSight Tumor enables high levels of sensitivity for minor allele detection (below 5%), with limited DNA input requirements.

“TruSight Tumor is designed to run on Illumina’s industry-leading sequencing platforms and enables clinical researchers to understand the molecular heterogeneity of FFPE tumor samples,” said Matt Posard, Senior Vice President and General Manager of Illumina’s Translational and Consumer Genomics business. “This technology has the potential to expand candidates for targeted therapies who may otherwise be missed with single variant or single gene approaches.”

“Tumor characterization using next-generation sequencing enables clinical research laboratories to gain a deeper understanding of underlying biology. In order to detect clinically relevant variants, it is important to look beyond single genes or hotspot mutations while achieving very low levels of sensitivity,” said Dr. Robert Daber, Technical Director of Clinical Genomics, Center for Personalized Diagnostics, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania.

TruSight Tumor is the first content set designed for somatic variant detection on the Illumina MiSeq® platform. As a portfolio, TruSight content sets are designed for high performance targeted sequencing to meet the specific needs of the clinical research laboratory by providing high analytical sensitivity and specificity. They offer exceptional performance in the capture and sequencing of targeted genomic regions, and are selected through collaborations with experts from leading institutions.

TruSight content sets are for research use only and not intended for diagnostic use. TruSight Tumor is now available for order with shipment expected in Q2’13. For more information, visit www.illumina.com/TruSightTumor.

…read more

Source: FULL ARTICLE at DailyFinance

Automobiles

Toyota Reveals Updated TS030 WEC Hybrid Le Mans Prototype Racer

Leave a comment

By Austin Lindberg

Toyota Racing TS030 hybrid race car

Toyota’s attempt to beat Audi in the World Endurance Championship got off to a rocky start in 2012, but ended up rock solid. New-car teething problems and an accident during testing kept Toyota from the first two races last year, so the brand’s debut came at Le Mans. Tough crowd. Accidents, including Anthony Davidson’s terrifying crash at the end of the Mulsanne Straight ended the battle with Audi in France. But Toyota showed strength at the end of the season, taking the pole and winning three of the last four races: Brazil, China and at home in Japan.  At least that’s the corporate home as the competition program is run out of Toyota’s racing base in Cologne, Germany.

That is where the automaker unveiled its updated 2013 WEC challenger. The TS030′s hybrid system has been “fine-tuned.” Unlike Audi with its diesel engine/flywheel energy-recovery system combo, Toyota matches a 530-hp, 3.4-liter naturally-aspirated gasoline V-8 with a super capacitor that can add an extra 300 horsepower.

One last-minute decision in 2012 was to flow the added power to the rear wheels, rather than the fronts as Audi does. As a result, last year’s monocoque structure could accept either system. Pascal Vasselon, Technical Director for the team explained that, “… the 2012 car, being a laboratory car, was able to accept front and rear hybrid systems, so we have redesigned the monocoque to optimize it without the front motor. Last year’s performance was very satisfying and we felt we ticked most boxes so there has been no concept change, just refinement and optimization of the 2012 car.”

The aerodynamics have also been improved and to underline Toyota’s plans for the future, Hisatake Murata, Hybrid Project Leader, mentioned they were including some pre-testing of 2014 technologies. Which bodes well for next year’s new rules and Porsche’s return to WEC.

…read more
Source: FULL ARTICLE at Car & Driver